EXHIBIT 10.43

PROMISSORY NOTE
 

$703,339.33
June 17, 2013
Miami, Florida

                                                            
WHEREAS, Keith Houlihan (“Houlihan”) is a member of the Board and President of
Sanomedics International Holdings, Inc., a Delaware corporation (the “Company”),
is owed accrued, unpaid salary from the Company in the aggregage amount of
$703,339.33;

WHEREAS, the Company and Houlihan wish to issue a convertible note that includes
the obligations currently represented as accrued salary pursuant to the terms as
set forth in this note.

FOR VALUE RECEIVED, the undersigned, Sanomedics International Holdings, Inc., a
Delaware corporation ("Maker" or the “Company”), hereby promises to pay to the
order of Keith Houlihan, a director and officer of Maker ("Holder") the
principal sum of Seven Hundred Three Thousand Three Hundred Thirty Nine and
33/100 Dollars ($703,339.33)(the “Principal Amount”), on or by March 30, 2015
(the "Maturity Date"), plus accrued and unpaid interest as set forth below.

1.  Principal and interest shall be payable in lawful money of the United States
of America in immediately available funds, without any deduction, setoff or
counterclaim, at the address of Holder specified herein.

2. This Note shall bear interest on the unpaid principal amount hereof
commencing on the date hereof at a rate of 9% per annum. Upon the occurrence and
during the continuance of an Event of Default, interest shall accrue on the
unpaid principal amount of this Note, from the date of such default until the
earlier of the date the principal sum is paid in full or, if applicable, the
date such default is cured, at the rate of 15% per annum (but not higher than
the applicable maximum rate provided by law).  Accrued interest on the
outstanding principal amount of this Note shall be payable on the Maturity Date,
unless accelerated as a result of the occurrence of an Event of Default as set
forth below. The principal amount of this Note may not be prepaid without the
prior written consent of the Holder which may be withheld for any reason.

3. This Note and any ancillary documents entered into in connection therewith,
each as amended, extended or modified from time to time, are referred to
collectively herein as the "Transaction Documents".
 
 
1

--------------------------------------------------------------------------------

 

4. (a) Prepayment Conversion.  Notwithstanding anything contained in this Note
to the contrary, Holder of this Note is entitled, at his option, at any time
after the issuance of this Note, to convert all or any lesser portion of the
Principal Amount and accrued but unpaid interest into common stock of the Maker
(“Common Stock”) at a conversion price for each share of Common Stock equal to
at a price (the “Conversion Price”) which is equal to the lesser of: (i) the
Variable Conversion Price (as defined herein); and (ii) the Fixed Conversion
Price (as defined herein) (subject, in each case, to equitable adjustments for
stock splits, stock dividends or rights offerings by the Maker relating to the
Maker’s securities or the securities of any subsidiary of the Maker,
combinations, recapitalization, reclassifications, extraordinary distributions
and similar events).  The “Variable Conversion Price” shall mean the Applicable
Percentage (as defined herein) multiplied by the Market Price (as defined
herein).  “Market Price” means the average of the lowest three (3) Trading
Prices (as defined below) for the Common Stock during the ten (10) Trading Day
period ending one Trading Day prior to the date the Conversion Notice is sent by
the Holder to the Maker via facsimile (the “Conversion Date”).  “Trading Price”
means, for any security as of any date, the closing bid price on the
Over-the-Counter Bulletin Board, or applicable trading market (the “OTCBB”) as
reported by a reliable reporting service (“Reporting Service”) mutually
acceptable to Maker and Holder, or, if the OTCBB is not the principal trading
market for such security, the closing bid price of such security on the
principal securities exchange or trading market where such security is listed or
traded or, if no closing bid price of such security is available in any of the
foregoing manners, the average of the closing bid prices of any market makers
for such security that are listed in the “pink sheets” by the National Quotation
Bureau, Inc.  If the Trading Price cannot be calculated for such security on
such date in the manner provided above, the Trading Price shall be the fair
market value as mutually determined by the Maker and the holders of a majority
in interest of the Notes being converted for which the calculation of the
Trading Price is required in order to determine the Conversion Price of such
Notes.  “Trading Day” shall mean any day on which the Common Stock is traded for
any period on the OTCBB, or on the principal securities exchange or other
securities market on which the Common Stock is then being traded.  “Applicable
Percentage” shall mean 50%. “Fixed Conversion Price” shall mean $0.50. (The
Common stock into which the Note is converted shall be referred to in this
agreement as “Conversion Shares”),

(b) The Company will not issue fractional shares or scrip representing fractions
of shares of Common Stock on conversion, but the Company will round the number
of shares of Common Stock issuable up to the nearest whole share.  The date on
which a Notice of Conversion is given shall be deemed to be the date on which
the Holder notifies the Company of its intention to so convert by delivery, by
facsimile transmission or otherwise, of a copy of the Notice of
Conversion.  Notice of Conversion may be sent by facsimile to the Company, Attn:
Keith Houlihan, Fax.: 305-433-5129.  Upon receipt of the Notice of Conversion,
the Company shall immediately cause the issuance of the shares of common stock
subject to the notice.  The Holder will deliver this Note, together with
original executed copy of the Notice of Conversion, to the Company within three
(3) business days following the Conversion Date.  At the Maturity Date, the
Company will pay any unconverted Outstanding Principal Amount and accrued
Interest thereon, at the option of the Holder, in either (a) cash or (b) Common
Stock valued at a price equal to the Conversion Price determined as if the Note
was converted in accordance with its terms into Common Stock on the Maturity
Date.

(c) Adjustment Due to Dilutive Issuance.  If, at any time when the Note is
issued and outstanding, the Company issues or sells, or in accordance with this
Section 4(c) hereof is deemed to have issued or sold, any shares of Common Stock
for no consideration or for a consideration per share (before deduction of
reasonable expenses or commissions or underwriting discounts or allowances in
connection therewith) less than the Conversion Price in effect on the date of
such issuance (or deemed issuance) of such shares of Common Stock (a “Dilutive
Issuance”), then immediately upon the Dilutive Issuance, the Conversion Price
will be reduced to the amount of the consideration per share received by the
Company in such Dilutive Issuance.
 
 
2

--------------------------------------------------------------------------------

 

The Company shall be deemed to have issued or sold shares of Common Stock if the
Company in any manner issues or grants any warrants, rights or options (not
including employee stock option plans), whether or not immediately exercisable,
to subscribe for or to purchase Common Stock or other securities convertible
into or exchangeable for Common Stock (“Convertible Securities”) (such warrants,
rights and options to purchase Common Stock or Convertible Securities are
hereinafter referred to as “Options”) and the price per share for which Common
Stock is issuable upon the exercise of such Options is less than the Conversion
Price then in effect, then the Conversion Price shall be equal to such price per
share.  For purposes of the preceding sentence, the “price per share for which
Common Stock is issuable upon the exercise of such Options” is determined by
dividing (i) the total amount, if any, received or receivable by the Company as
consideration for the issuance or granting of all such Options, plus the minimum
aggregate amount of additional consideration, if any, payable to the Company
upon the exercise of all such Options, plus, in the case of Convertible
Securities issuable upon the exercise of such Options, the minimum aggregate
amount of additional consideration payable upon the conversion or exchange
thereof at the time such Convertible Securities first become convertible or
exchangeable, by (ii) the maximum total number of shares of Common Stock
issuable upon the exercise of all such Options (assuming full conversion of
Convertible Securities, if applicable).  No further adjustment to the Conversion
Price will be made upon the actual issuance of such Common Stock upon the
exercise of such Options or upon the conversion or exchange of Convertible
Securities issuable upon exercise of such Options.

Additionally, the Company shall be deemed to have issued or sold shares of
Common Stock if the Company in any manner issues or sells any Convertible
Securities, whether or not immediately convertible (other than where the same
are issuable upon the exercise of Options), and the price per share for which
Common Stock is issuable upon such conversion or exchange is less than the
Conversion Price then in effect, then the Conversion Price shall be equal to
such price per share.  For the purposes of the preceding sentence, the “price
per share for which Common Stock is issuable upon such conversion or exchange”
is determined by dividing (i) the total amount, if any, received or receivable
by the Company as consideration for the issuance or sale of all such Convertible
Securities, plus the minimum aggregate amount of additional consideration, if
any, payable to the Company upon the conversion or exchange thereof at the time
such Convertible Securities first become convertible or exchangeable, by (ii)
the maximum total number of shares of Common Stock issuable upon the conversion
or exchange of all such Convertible Securities.  No further adjustment to the
Conversion Price will be made upon the actual issuance of such Common Stock upon
conversion or exchange of such Convertible Securities.

5. The unpaid principal amount of this Note, the accrued interest thereon and
all other obligations of Maker hereunder (collectively, the "Obligations"), at
the option of Holder, shall become immediately due and payable upon the
occurrence of any of the following events of default ("Events of Default"):

(a) Maker shall fail to pay: (i) any principal or accrued interest under this
Note within ten (10) days after the Maturity Date; or (ii) any of the other
monetary Obligations to be paid by it under this Note within ten (10) days of
the due date for payment of same.

(b) Maker shall default in the observance or performance of any material
agreements, covenants or conditions contained in: (i) this Note, the Transaction
Documents or in any other document or instrument referred to herein or therein
(except the failure to pay monetary Obligations); or (ii) any agreement by and
between the Maker and the Holder; and fail to cure such default within ten (10)
business days of the date Maker obtains notice thereof whether from Holder or
otherwise.
 
 
3

--------------------------------------------------------------------------------

 
 
(c) Any present or future representation or warranty made by or on behalf of
Maker whether contained herein or in any of the other document shall be false or
incorrect in any material respect when such representation or warranty is made.

(d) The occurrence of any of the following with respect to Maker: dissolution;
termination of existence; insolvency; business cessation; calling of a meeting
of creditors; appointment of a receiver for any property; assignment for the
benefit of creditors or admit in writing its inability to pay its debts as they
become due; voluntary commencement of any proceeding under any bankruptcy or
insolvency law; commencement of any involuntary proceeding under any bankruptcy
or insolvency law and if any such involuntary proceeding is not dismissed within
45 days or the relief requested is granted; entry of a court order which enjoins
or restrains the conduct of business in the ordinary course.

6. Maker shall reimburse Holder for all costs and expenses incurred by Holder
and shall pay the reasonable fees, disbursements and out of pocket expenses of
counsel to Holder in connection with the enforcement of Holder's rights
hereunder.  Maker shall also pay any and all taxes (other than taxes on or
measured by net income of the holder of this Note) recording fees, filing
charges, search fees or similar items incurred or payable in connection with the
execution and delivery of this Note.

7. Maker waives demand, presentment, protest and notice of any kind and consents
to the release, surrender or substitution of any and all security or guarantees
for the Obligations evidenced hereby or other indulgence with respect to this
Note, all without notice.

8. Maker shall indemnify, defend and save Holder harmless from and against any
and all claims, liabilities, losses, costs and expenses (including, without
limitation, reasonable attorneys' fees, disbursements and out of pocket
expenses) of any nature whatsoever which may be asserted against or incurred by
Holder arising out of or in any manner occasioned by or any failure by Maker to
perform any of its Obligations hereunder.

9. Maker agrees to do such further acts and to execute and deliver to Holder
such additional agreements, instruments and documents as Holder may reasonably
require or deem advisable to effectuate the purposes of this Note, or to confirm
to Holder its rights, powers and remedies under this Note.

10. (a)  Any notice or other communication required or permitted hereunder shall
be in writing and shall be delivered or transmitted personally by messenger, by
recognized overnight courier, telecopied or mailed (by registered or certified
mail, postage prepaid) as follows:  
 
 
4

--------------------------------------------------------------------------------

 

(i) If to Maker, one copy to:

Sanomedics International Holdings, Inc.
444 Brickell Avenue, Suite 415
Miami, Florida 33131

(ii)  If to the Holder:

Keith Houlihan
c/o Sanomedics International Holdings, Inc.
444 Brickell Avenue, Suite 415
Miami, Florida 33131

(b) Each such notice or other communication shall be effective: (i) if given by
telecopier, when such telecopy is transmitted to the telecopier number specified
in Section 10(a) (with confirmation of transmission received by the sender); or
(ii) if given by any other means, when received at the address specified in
Section 10(a).  Any party by notice given in accordance with this Section 10 to
the other party may designate another address (or telecopier number) or person
for receipt of notices hereunder.
 
11. This Note contain the entire agreement between the parties with respect to
the subject matter hereof and supersedes all prior agreements, written or oral,
with respect thereto including the Convertible Notes which upon the execution
and delivery of this Note shall be terminated and of no further force or effect.

12. This Note may be amended, superseded, cancelled, renewed or extended only by
a written instrument signed by Holder and Maker.  Any provisions hereof may be
waived by a party but any such waiver must be in writing signed by such party
and any such waiver shall be effective only in the specific instance and for the
specific purpose for which given.  No delay on the part of any party in
exercising any right, power or privilege hereunder shall operate as a waiver
thereof, nor shall any waiver on the part of any party of any such right, power
or privilege, nor any single or partial exercise of any such right, power or
privilege, preclude any further exercise thereof or the exercise of any other
such right, power or privilege.  The rights and remedies herein provided are
cumulative and are not exclusive of any rights or remedies that any party may
otherwise have at law or in equity.
 
 
5

--------------------------------------------------------------------------------

 

13. This Agreement shall be governed by and construed in accordance with the
laws of the State of Florida applicable to agreements made and to be performed
entirely within such State, without regard to the conflict of laws rules
thereof.

14. Maker irrevocably: (a) agrees that any suit, action or other legal
proceeding arising out of this Agreement may be brought in the courts of the
State of Florida or the courts of the United States located in Dade County,
Florida; (b) consents to the jurisdiction of each court in any such suit, action
or proceeding; (c) waives any objection which it may have to the laying of venue
of any such suit, action or proceeding in any of such courts; (d) waives the
right to assert any counterclaim in any such suit, action and proceeding; and
(e) waives the right to a trial by jury in any such suit, action or other legal
proceeding.  

15. This Note and all of its provisions, rights and Obligations shall be binding
upon and shall inure to the benefit of the parties hereto and their respective
successors, assigns and legal representatives.  Nothing herein express or
implied is intended or shall be construed to confer upon or to give anyone other
than the parties hereto and their respective heirs, legal representatives and
successors any rights or benefits under or by reason of this Agreement and no
other party shall have any right to enforce any of the provisions of this
Agreement.  This note may be transferred or assigned by the Holder, in full or
in part.

16. If any provision of this Note for any reason shall be held to be illegal,
invalid or unenforceable, such illegality shall not affect any other provision
of this Note, but this Note shall be construed as if such illegal, invalid or
unenforceable provision had never been included herein.
 
 
6

--------------------------------------------------------------------------------

 
 
IN WITNESS WHEREOF, the undersigned has executed this Promissory Note as of the
date first written above.
 
 

ATTEST:
MAKER:
Sanomedics International Holdings, Inc.,
          /s/  Miriam Sardinas  
By:
/s/ David Langle       Name: David Langle       Title: Chief Financial Officer
and by resolution of the members of the Board of Directors)          

 
 
 
 
7

--------------------------------------------------------------------------------

 

Exhibit A
Conversion Notice
NOTICE OF CONVERSION
 
The undersigned hereby elects to convert $____________ principal amount of the
Note (defined below) into that number of shares of Common Stock to be issued
pursuant to the conversion of the Note (“Common Stock”) as set forth below, of
Sanomedics International Holdings, Inc., a Delaware corporation (the “Borrower”)
according to the conditions of the convertible note of the Borrower dated as of
[insert date of note] (the “Note”), as of the date written below.  No fee will
be charged to the Holder for any conversion, except for transfer taxes, if
any.  

Box Checked as to applicable instructions:

[ ]
The Borrower shall electronically transmit the Common Stock issuable pursuant to
this Notice of Conversion to the account of the undersigned or its nominee with
DTC through its Deposit Withdrawal Agent Commission system (“DWAC Transfer”).

Name of DTC Prime Broker:   
Account Number:  

[  ]
The undersigned hereby requests that the Borrower issue a certificate or
certificates for the number of shares of Common Stock set forth below (which
numbers are based on the Holder’s calculation attached hereto) in the name(s)
specified immediately below or, if additional space is necessary, on an
attachment hereto:

 
Date of Conversion:  
Applicable Conversion Price:
Number of Shares of Common Stock to be Issued Pursuant to
Conversion of the Notes:  
Amount of Principal Balance Due on Note being Converted:

BY_____________________________
Name:

Date: _________
Address:

 
 8

--------------------------------------------------------------------------------